Is a complete TMCI research report available?

No complete published report is available for Treace Medical Concepts, Inc. (TMCI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Treace Medical Concepts, Inc. (TMCI)

NASDAQ: TMCI · USD

$4.81

+0.26 (+5.7%)· Recorded snapshot

Market cap	312.8M
Revenue (ttm)	205.3M
Net income (ttm)	-59.5M
EPS (ttm)	-$0.93
Shares out	65M
Volume	159,016
Beta	1.49

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 205.3M
Net income (ttm): -59.5M
EPS (ttm): -$0.93
Market cap: 312.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001630627
Company name	Treace Medical Concepts, Inc.
Country	United States
Country code	US
CUSIP number	89455T109
Earnings date	2026-11-06
Earnings time	bmo
Employees	450
Employees change	-27
Employees growth	-5.66%
Enterprise value	$340.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
Industry	Medical Devices
IPO date	2021-04-23
Is primary listing	Yes
Is SPAC	No
ISIN number	US89455T1097
Last 10-K release date	2026-02-27
Last earnings date	2026-08-07
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$312.8M
Market cap category	Micro-Cap
Next earnings date	2026-11-06
Options	Yes
Price	$4.81
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	TMCI
U.S. state	Florida
Website	https://www.treace.com

Metric

Value

Amount currency

USD

CIK code

0001630627

Company name

Treace Medical Concepts, Inc.

Country

United States

Country code

CUSIP number

89455T109

Earnings date

2026-11-06

Earnings time

bmo

Employees

450

Employees change

-27

Employees growth

-5.66%

Enterprise value

$340.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

Industry

Medical Devices

IPO date

2021-04-23

Is primary listing

Yes

Is SPAC

ISIN number

US89455T1097

Last 10-K release date

2026-02-27

Last earnings date

2026-08-07

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$312.8M

Market cap category

Micro-Cap

Next earnings date

2026-11-06

Options

Yes

Price

$4.81

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

TMCI

U.S. state

Florida

Website

https://www.treace.com

Metric	Value
Earnings yield	-19.26%
EV/Sales	1.65x
FCF / EV yield	-7.4%
FCF yield	-8.06%
Forward EV/Sales	1.57x
Forward P/S	1.44x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	4.36x
P/S ratio	1.51x
Price / tangible book value	6.44x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-19.26%

EV/Sales

1.65x

FCF / EV yield

-7.4%

FCF yield

-8.06%

Forward EV/Sales

1.57x

Forward P/S

1.44x

Industry forward P/E

19.81x

Industry P/E

39.28x

P/B ratio

4.36x

P/S ratio

1.51x

Price / tangible book value

6.44x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-26.17%
EBITDA margin	-22.58%
Gross margin	79.45%
Operating margin	-26.17%
Pretax margin	-28.99%
Profit margin	-28.99%
Profit per employee	$-132,258
Revenue per employee	$456,238
ROA	-17.33%
ROA (5Y)	-14.58%
ROCE	-38.49%
ROE	-71.99%
ROE (5Y)	-50.57%
ROIC	-21.77%
SBC / revenue	14.64%

Metric

Value

EBIT margin

-26.17%

EBITDA margin

-22.58%

Gross margin

79.45%

Operating margin

-26.17%

Pretax margin

-28.99%

Profit margin

-28.99%

Profit per employee

$-132,258

Revenue per employee

$456,238

ROA

-17.33%

ROA (5Y)

-14.58%

ROCE

-38.49%

ROE

-71.99%

ROE (5Y)

-50.57%

ROIC

-21.77%

SBC / revenue

14.64%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-4.75%
Gross profit growth (Q)	-5.68%
Gross profit growth 3Y	6.21%
Gross profit growth 5Y	21.16%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-3.95%
Revenue growth (Q)	-4.24%
Revenue growth (QoQ)	-3.86%
Revenue growth 3Y	7.13%
Revenue growth 5Y	21.44%
Revenue growth years	6

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-4.75%

Gross profit growth (Q)

-5.68%

Gross profit growth 3Y

6.21%

Gross profit growth 5Y

21.16%

Net income growth quarters

Net income growth years

Revenue growth

-3.95%

Revenue growth (Q)

-4.24%

Revenue growth (QoQ)

-3.86%

Revenue growth 3Y

7.13%

Revenue growth 5Y

21.44%

Revenue growth years

Metric	Value
Capital expenditures	$-10.5M
Depreciation and amortization	$7.4M
EBIT	$-53.7M
EBITDA	$-46.4M
EPS	$-0.93
FCF per share	$-0.39
Financing cash flow	$1.5M
Free cash flow	$-25M
Free cash flow minus SBC	$-55.1M
Gross profit	$163.1M
Investing cash flow	$17.7M
Net borrowing	$3M
Net cash flow	$4.6M
Net income	$-59.5M
Operating cash flow minus SBC	$-44.6M
Operating income	$-53.7M
Revenue	$205.3M
Stock-based compensation	$30.1M

Metric

Value

Capital expenditures

$-10.5M

Depreciation and amortization

$7.4M

EBIT

$-53.7M

EBITDA

$-46.4M

EPS

$-0.93

FCF per share

$-0.39

Financing cash flow

$1.5M

Free cash flow

$-25M

Free cash flow minus SBC

$-55.1M

Gross profit

$163.1M

Investing cash flow

$17.7M

Net borrowing

$3M

Net cash flow

$4.6M

Net income

$-59.5M

Operating cash flow minus SBC

$-44.6M

Operating income

$-53.7M

Revenue

$205.3M

Stock-based compensation

$30.1M

Metric	Value
Altman Z-Score	-0.18
Book value per share	$1.04
Debt / equity	1.08
Goodwill	$12.8M
Interest coverage	-9.23
Long-term assets	$60.6M
Long-term liabilities	$71.8M
Net cash (debt)	$-27.4M
Net cash / market cap	-8.82%
Net debt / equity	0.4
Piotroski F-Score	2
Property, plant and equipment	$39.6M
Shareholders' equity	$67.7M
Tangible book value	$48.3M
Tangible book value per share	$0.74
Total assets	$181.1M
Total cash	$45.6M
Total debt	$73.1M
Total liabilities	$113.3M
WACC	11.26%

Metric

Value

Altman Z-Score

-0.18

Book value per share

$1.04

Debt / equity

1.08

Goodwill

$12.8M

Interest coverage

-9.23

Long-term assets

$60.6M

Long-term liabilities

$71.8M

Net cash (debt)

$-27.4M

Net cash / market cap

-8.82%

Net debt / equity

0.4

Piotroski F-Score

Property, plant and equipment

$39.6M

Shareholders' equity

$67.7M

Tangible book value

$48.3M

Tangible book value per share

$0.74

Total assets

$181.1M

Total cash

$45.6M

Total debt

$73.1M

Total liabilities

$113.3M

WACC

11.26%

Metric	Value
Asset turnover	1.06
Current assets	$120.5M
Current liabilities	$41.5M
Current ratio	2.9
Inventory turnover	1.03
Net working capital	$37.3M
Quick ratio	1.8
Working capital	$79M
Working capital turnover	2.22

Metric

Value

Asset turnover

1.06

Current assets

$120.5M

Current liabilities

$41.5M

Current ratio

2.9

Inventory turnover

1.03

Net working capital

$37.3M

Quick ratio

1.8

Working capital

$79M

Working capital turnover

2.22

Metric	Value
Buyback yield / dilution	-2.71%
Dividend yield	0%
Shareholder yield	-2.71%

Metric

Value

Buyback yield / dilution

-2.71%

Dividend yield

Shareholder yield

-2.71%

Metric	Value
150-day SMA	$3.64
1D price change	5.71%
1M price change	6.89%
1M total return	6.89%
1W price change	18.18%
1W total return	18.18%
1Y price change	-29.78%
1Y return CAGR	-29.8%
1Y total return	-29.78%
20-day SMA	$4.18
200-day SMA	$3.22
3M price change	17.89%
3M total return	17.89%
3Y price change	-49.37%
3Y return CAGR	-20.29%
3Y total return	-49.37%
50-day SMA	$4.42
50-day SMA vs 200-day SMA	50over200
52-week high	$6.91
52-week high date	2025-10-29
52-week low	$1.17
52-week low date	2026-03-30
5Y price change	-79.15%
5Y return CAGR	-26.92%
5Y total return	-79.15%
6M price change	150.52%
6M total return	150.52%
All-time high	$37.17
All-time high date	2021-06-14
All-time low	$1.17
All-time low date	2026-03-30
Average true range (ATR)	$0.23
Average volume	208K
Beta (1Y)	3.42
Beta (2Y)	2.51
Beta (5Y)	1.49
Change from 52-week high	-30.39%
Change from 52-week low	311.11%
Change from all-time high	-87.06%
Change from all-time low	311.11%
Change from open	3.66%
Day's gap	1.98%
Dollar volume	$764,867
High price	$4.81
Low price	$4.64
Monthly RSI	44.39
Open price	$4.64
Position in 52-week range	100%
Premarket change	-0.88%
Premarket close	$4.55
Premarket price	$4.51
Previous close	$4.55
Price vs 150-day SMA	32.14%
Price vs 20-day SMA	15.13%
Price vs 200-day SMA	49.61%
Price vs 50-day SMA	8.95%
Relative volume	0.76
Return from IPO open	-80.49%
Return from IPO price	-71.88%
RSI	66.46
Sharpe ratio	-0
Sharpe ratio (3Y)	0.15
Sharpe ratio (5Y)	-0.05
Sortino ratio	0.06
Sortino ratio (3Y)	0.27
Sortino ratio (5Y)	0.01
Volume	159K
Weekly RSI	61.46
YTD price change	96.33%
YTD total return	96.33%

Metric

Value

150-day SMA

$3.64

1D price change

5.71%

1M price change

6.89%

1M total return

6.89%

1W price change

18.18%

1W total return

18.18%

1Y price change

-29.78%

1Y return CAGR

-29.8%

1Y total return

-29.78%

20-day SMA

$4.18

200-day SMA

$3.22

3M price change

17.89%

3M total return

17.89%

3Y price change

-49.37%

3Y return CAGR

-20.29%

3Y total return

-49.37%

50-day SMA

$4.42

50-day SMA vs 200-day SMA

50over200

52-week high

$6.91

52-week high date

2025-10-29

52-week low

$1.17

52-week low date

2026-03-30

5Y price change

-79.15%

5Y return CAGR

-26.92%

5Y total return

-79.15%

6M price change

150.52%

6M total return

150.52%

All-time high

$37.17

All-time high date

2021-06-14

All-time low

$1.17

All-time low date

2026-03-30

Average true range (ATR)

$0.23

Average volume

208K

Beta (1Y)

3.42

Beta (2Y)

2.51

Beta (5Y)

1.49

Change from 52-week high

-30.39%

Change from 52-week low

311.11%

Change from all-time high

-87.06%

Change from all-time low

311.11%

Change from open

3.66%

Day's gap

1.98%

Dollar volume

$764,867

High price

$4.81

Low price

$4.64

Monthly RSI

44.39

Open price

$4.64

Position in 52-week range

100%

Premarket change

-0.88%

Premarket close

$4.55

Premarket price

$4.51

Previous close

$4.55

Price vs 150-day SMA

32.14%

Price vs 20-day SMA

15.13%

Price vs 200-day SMA

49.61%

Price vs 50-day SMA

8.95%

Relative volume

0.76

Return from IPO open

-80.49%

Return from IPO price

-71.88%

RSI

66.46

Sharpe ratio

-0

Sharpe ratio (3Y)

0.15

Sharpe ratio (5Y)

-0.05

Sortino ratio

0.06

Sortino ratio (3Y)

0.27

Sortino ratio (5Y)

0.01

Volume

159K

Weekly RSI

61.46

YTD price change

96.33%

YTD total return

96.33%

Metric	Value
Float	47.8M
Float percentage	73.49%
Shares change (QoQ)	0.71%
Shares change (YoY)	2.71%
Shares held by insiders	26.51%
Shares held by institutions	39.4%
Shares outstanding	65M
Short % of float	4.14%
Short % of shares	3.04%
Short ratio	8.9 days

Metric

Value

Float

47.8M

Float percentage

73.49%

Shares change (QoQ)

0.71%

Shares change (YoY)

2.71%

Shares held by insiders

26.51%

Shares held by institutions

39.4%

Shares outstanding

65M

Short % of float

4.14%

Short % of shares

3.04%

Short ratio

8.9 days

Treace Medical Concepts, Inc. (TMCI)

Price

Financial snapshot

Fair-value bridge

Latest news · TMCI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TMCI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TMCI

Frequently asked questions